mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for DMD
Gene summary
Basic gene Info.Gene symbolDMD
Gene namedystrophin
SynonymsBMD|CMD3B|DXS142|DXS164|DXS206|DXS230|DXS239|DXS268|DXS269|DXS270|DXS272|MRX85
CytomapUCSC genome browser: Xp21.2
Type of geneprotein-coding
RefGenesNM_000109.3,
NM_004006.2,NM_004009.3,NM_004010.3,NM_004011.3,
NM_004012.3,NM_004013.2,NM_004014.2,NM_004015.2,
NM_004016.2,NM_004017.2,NM_004018.2,NM_004019.2,
NM_004020.3,NM_004021.2,NM_004022.2,NM_004023.2,
NM_004007.2,
Description-
Modification date20141219
dbXrefs MIM : 300377
HGNC : HGNC
Ensembl : ENSG00000198947
HPRD : 02303
Vega : OTTHUMG00000021336
ProteinUniProt: P11532
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_DMD
BioGPS: 1756
PathwayNCI Pathway Interaction Database: DMD
KEGG: DMD
REACTOME: DMD
Pathway Commons: DMD
ContextiHOP: DMD
ligand binding site mutation search in PubMed: DMD
UCL Cancer Institute: DMD
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0043043peptide biosynthetic process16000376


Top
Ligand binding site mutations for DMD
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
T3188R3187HCOAD2
Q3079P3078HLUAD1
Y3072T3072KLUAD1
T3188R3187PUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.

Clinical information for DMD from My Cancer Genome.
Dystrophin (DMD) is a gene that encodes a protein that functions in extracellular matrix degradation and non-integrin membrane-extracellular matrix interaction pathways. Missense mutations, silent mutations, nonsense mutations, and frameshift deletions are observed in cancers such as colon cancer, endometrial cancer, and skin cancer. Modified: August 27, 2015

Top
Protein structure related information for DMD
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for DMD from PDB
PDB IDPDB titlePDB structure
1DXXN-TERMINAL ACTIN-BINDING DOMAIN OF HUMAN DYSTROPHIN

Top
Differential gene expression and gene-gene network for DMD
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of DMD and the right PPI network was created from samples without mutations in the LBS of DMD. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for DMD
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0013264Muscular Dystrophy, Duchenne510AlteredExpression, Biomarker, GeneticVariation
umls:C0026850Muscular Dystrophies451AlteredExpression, Biomarker, GeneticVariation, Therapeutic
umls:C0917713Becker muscular dystrophy198Biomarker, GeneticVariation
umls:C0007193Cardiomyopathy, Dilated40AlteredExpression, Biomarker, GeneticVariation
umls:C0878544Cardiomyopathies35Biomarker, GeneticVariation, Therapeutic
umls:C3714570Dilated cardiomyopathy 3B33AlteredExpression, Biomarker, GeneticVariation
umls:C0206656Rhabdomyosarcoma, Embryonal2Biomarker
umls:C0038220Status Epilepticus1Biomarker
umls:C0238198Gastrointestinal Stromal Tumors1Biomarker
umls:C0006663Calcinosis1Biomarker
umls:C0018800Cardiomegaly1Biomarker
umls:C0012644Disease Models, Animal1Biomarker
umls:C0023269Leiomyosarcoma1Biomarker
umls:C0026851Muscular Dystrophy, Animal1Biomarker
umls:C0027540Necrosis1Biomarker
umls:C0027626Neoplasm Invasiveness1Biomarker
umls:C0027627Neoplasm Metastasis1Biomarker
umls:C0032460Polycystic Ovary Syndrome1Biomarker
umls:C0242973Ventricular Dysfunction1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for DMD
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of DMD go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of DMD
Multiple alignments for P11532 in multiple species
LBSAA sequence# speciesSpecies
G3189NVYDTGRTGRI3Homo sapiens, Mus musculus, Canis lupus familiaris
H3076PYYINHETQTT3Homo sapiens, Mus musculus, Canis lupus familiaris
I3074KVPYYINHETQ3Homo sapiens, Mus musculus, Canis lupus familiaris
N3068RAISPNKVPYY3Homo sapiens, Mus musculus, Canis lupus familiaris
Q3079INHETQTTCWD3Homo sapiens, Mus musculus, Canis lupus familiaris
R3190VYDTGRTGRIR3Homo sapiens, Mus musculus, Canis lupus familiaris
S3066WERAISPNKVP3Homo sapiens, Mus musculus, Canis lupus familiaris
T3081HETQTTCWDHP3Homo sapiens, Mus musculus, Canis lupus familiaris
T3188LNVYDTGRTGR3Homo sapiens, Mus musculus, Canis lupus familiaris
W3083TQTTCWDHPKM3Homo sapiens, Mus musculus, Canis lupus familiaris
Y3072PNKVPYYINHE3Homo sapiens, Mus musculus, Canis lupus familiaris


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas